134 related articles for article (PubMed ID: 11580846)
1. The KEX2 gene of Candida glabrata is required for cell surface integrity.
Bader O; Schaller M; Klein S; Kukula J; Haack K; Mühlschlegel F; Korting HC; Schäfer W; Hube B
Mol Microbiol; 2001 Sep; 41(6):1431-44. PubMed ID: 11580846
[TBL] [Abstract][Full Text] [Related]
2. KEX2 influences Candida albicans proteinase secretion and hyphal formation.
Newport G; Agabian N
J Biol Chem; 1997 Nov; 272(46):28954-61. PubMed ID: 9360967
[TBL] [Abstract][Full Text] [Related]
3. Processing of predicted substrates of fungal Kex2 proteinases from Candida albicans, C. glabrata, Saccharomyces cerevisiae and Pichia pastoris.
Bader O; Krauke Y; Hube B
BMC Microbiol; 2008 Jul; 8():116. PubMed ID: 18625069
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of Kex2p diminishes the virulence of Candida albicans.
Newport G; Kuo A; Flattery A; Gill C; Blake JJ; Kurtz MB; Abruzzo GK; Agabian N
J Biol Chem; 2003 Jan; 278(3):1713-20. PubMed ID: 12419804
[TBL] [Abstract][Full Text] [Related]
5. A GAS-like gene family in the pathogenic fungus Candida glabrata.
Weig M; Haynes K; Rogers TR; Kurzai O; Frosch M; Mühlschlegel FA
Microbiology (Reading); 2001 Aug; 147(Pt 8):2007-2019. PubMed ID: 11495979
[TBL] [Abstract][Full Text] [Related]
6. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in
Kapoor M; Moloney M; Soltow QA; Pillar CM; Shaw KJ
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611349
[TBL] [Abstract][Full Text] [Related]
8. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
9. Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata.
Minematsu A; Miyazaki T; Shimamura S; Nishikawa H; Nakayama H; Takazono T; Saijo T; Yamamoto K; Imamura Y; Yanagihara K; Kohno S; Mukae H; Izumikawa K
PLoS One; 2019; 14(1):e0210883. PubMed ID: 30673768
[TBL] [Abstract][Full Text] [Related]
10. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.
Vermitsky JP; Edlind TD
Antimicrob Agents Chemother; 2004 Oct; 48(10):3773-81. PubMed ID: 15388433
[TBL] [Abstract][Full Text] [Related]
11. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
[TBL] [Abstract][Full Text] [Related]
12. Deletion of
Yu SJ; Chang YL; Chen YL
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311082
[No Abstract] [Full Text] [Related]
13. Mutations in the yeast KEX2 gene cause a Vma(-)-like phenotype: a possible role for the Kex2 endoprotease in vacuolar acidification.
Oluwatosin YE; Kane PM
Mol Cell Biol; 1998 Mar; 18(3):1534-43. PubMed ID: 9488470
[TBL] [Abstract][Full Text] [Related]
14. Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.
Siikala E; Rautemaa R; Richardson M; Saxen H; Bowyer P; Sanglard D
J Antimicrob Chemother; 2010 Dec; 65(12):2505-13. PubMed ID: 20876623
[TBL] [Abstract][Full Text] [Related]
15. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
17. Cloning and rational mutagenesis of kexstatin I, a potent proteinaceous inhibitor of Kex2 proteinase.
Oda K; Oyama H; Ito S; Fukiharu M; Miyagawa Y; Takahashi S; Hirose M; Kikuchi N; Nakayama T; Shibano Y
Biochem J; 2001 Apr; 355(Pt 2):339-46. PubMed ID: 11284720
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility.
Geber A; Hitchcock CA; Swartz JE; Pullen FS; Marsden KE; Kwon-Chung KJ; Bennett JE
Antimicrob Agents Chemother; 1995 Dec; 39(12):2708-17. PubMed ID: 8593007
[TBL] [Abstract][Full Text] [Related]
19. The kex2 gene from the dimorphic and human pathogenic fungus Paracoccidioides brasiliensis.
Venancio EJ; Daher BS; Andrade RV; Soares CM; Pereira IS; Felipe MS
Yeast; 2002 Oct; 19(14):1221-31. PubMed ID: 12271458
[TBL] [Abstract][Full Text] [Related]
20. Amino acid substitutions in Erg11p of azole-resistant Candida glabrata: Possible effective substitutions and homology modelling.
Nabili M; Abdollahi Gohar A; Badali H; Mohammadi R; Moazeni M
J Glob Antimicrob Resist; 2016 Jun; 5():42-6. PubMed ID: 27436465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
